Alzamend Neuro (ALZN) Research & Development (2020 - 2026)
Alzamend Neuro (ALZN) reported Research & Development of $1.09 million for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 37.6% from $1.74 million a year earlier but up 150.2% from the prior quarter.
Powered by 
Analysis
Alzamend Neuro (ALZN) Research & Development (2020 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Alzamend Neuro's Research & Development came in at $2.97 million, up 0.9% year-over-year; for FY2026 (ended Apr 30, 2026), it was $3.63 million, up 156.5% from FY2025.
- Research & Development has a five-year compound annual growth rate of 22.6% (FY2021 to FY2026).
- By fiscal year, Research & Development came in at $1.41 million in FY2025 (-78.1%), $6.46 million in FY2024 (-13.3%), $7.45 million in FY2023 (+43.2%) and $5.2 million in FY2022 (+296.8%).
- Five-year quarterly Research & Development spans a low of $176,283 in fiscal Q2 2026 and a high of $2.89 million in fiscal Q3 2023.
- Year over year, Research & Development gained in three of the last eight quarters, with growth averaging 103.6%.
- The high point for year-over-year Research & Development in five years was fiscal Q1 2026 (growth of 742.7%); the low point was fiscal Q1 2025 (a decline of 91.3%).
- Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $434,006 (Q4 2026), $1.28 million (Q3 2026) and $176,283 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Alzamend Neuro | 8.35 Mn | 8.35 Mn | - | 1.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 1.09 Mn |
| Apr 30, 2026 | 434,006.00 |
| Jan 31, 2026 | 1.28 Mn |
| Oct 31, 2025 | 176,283.00 |
| Jul 31, 2025 | 1.74 Mn |
| Apr 30, 2025 | 450,157.00 |
| Jan 31, 2025 | 447,111.00 |
| Oct 31, 2024 | 311,088.00 |
| Jul 31, 2024 | 206,571.00 |
| Apr 30, 2024 | 183,430.00 |
| Jan 31, 2024 | 1.91 Mn |
| Oct 31, 2023 | 2.00 Mn |
| Jul 31, 2023 | 2.37 Mn |
| Apr 30, 2023 | 1.65 Mn |
| Jan 31, 2023 | 2.89 Mn |
| Oct 31, 2022 | 1.53 Mn |
| Jul 31, 2022 | 1.38 Mn |
| Apr 30, 2022 | 1.66 Mn |
| Jan 31, 2022 | 873,653.00 |
| Oct 31, 2021 | 1.75 Mn |
API Access
Alzamend Neuro Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ALZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ALZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ALZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();